Osaka University:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Osaka University - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9292
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:39
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:日本
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Osaka University (OU) is an educational university that provides undergraduate and graduate courses. The university provides courses in dentistry, economics, engineering, engineering science, foreign studies, human sciences, law and politics, medicine, information science and technology, language and culture, pharmaceutical sciences and biosciences, among others. It offers research areas such as microbial diseases, scientific and industrial research, protein research, social and economic, laser engineering, joining and welding research, and others. OU provides hospital services such as dental and university hospital services. The University has operations in the US, Thailand, China and the Netherlands, among others. OU is headquartered in Suita, Japan.

Osaka University – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Osaka University, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Osaka University, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Osaka University, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Osaka University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Osaka University, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Osaka University, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Mitsubishi Tanabe Pharma and Osaka University Enter into Agreement 11
KAN Research Institute Enters into Development Agreement with Six Research Organizations 12
Mitsubishi Tanabe Pharma Forms Joint Venture with Research Foundation for Microbial Diseases of Osaka University 14
Oncolys Biopharma Enters into Research Agreement with Osaka University 15
BIKEN Enters into Distribution Agreement with Chiba Prefectural Institute of Health 16
Chugai Pharmaceutical Enters into Agreement with Osaka University 17
Takeda Pharma Enters Into Co-Marketing Agreement With Research Foundation For Microbial Diseases Of Osaka University 18
Takeda Pharma Enters Into Research Agreement With Osaka University 19
Licensing Agreements 20
Japan Agency for Medical Research and Development Enters into Licensing Agreement with Osaka University 20
NobelPharma Enters into Licensing Agreement with Osaka University 21
BIKEN Enters into Licensing Agreement with Osaka University 22
FunPep Enters into Licensing Agreement with Osaka University 23
Osaka University – Key Competitors 24
Osaka University – Key Employees 25
Osaka University – Locations And Subsidiaries 26
Head Office 26
Other Locations & Subsidiaries 26
Recent Developments 28
Government and Public Interest 28
Aug 09, 2018: Anticancer drugs delivered by a new drug delivery system reduce tumor size 28
May 30, 2018: Telix Pharmaceuticals and Osaka University receive Japan Science and Technology Agency Funding for Alpha Nuclide Research 29
Apr 18, 2018: Researchers uncover origin of virus-fighting plasma B cells 30
Dec 20, 2017: CD4 T Cells, Xenobiotic Transporters, and Metabolites in Inflammatory Bowel Diseases 31
Nov 07, 2017: Osaka University: New Strategy for Multiple Myeloma Immunotherapy 32
Oct 26, 2017: Successful Cardiogenic Shock Treatment Using a Percutaneous Left Ventricular Assist Device 33
Sep 15, 2017: Novel Small Antibody Fragment: A Valuable Tool in Crystallography 34
Aug 22, 2017: The Pancreas provides a potential drug candidate for brain disease 35
Product News 36
Oct 29, 2018: Experimental vaccine may reduce post-stroke blood clot risk 36
Mar 26, 2018: New Breakthrough in Treatment for Rare Skin Condition 37
Other Significant Developments 38
Jul 02, 2018: Mitsubishi Tanabe Pharma and Osaka University co-found the “Department of Neuro-Medical Science” 38
Appendix 39
Methodology 39
About GlobalData 39
Contact Us 39
Disclaimer 39

List of Tables
Osaka University, Pharmaceuticals & Healthcare, Key Facts 2
Osaka University, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Osaka University, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Osaka University, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Osaka University, Deals By Therapy Area, 2012 to YTD 2018 8
Osaka University, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Mitsubishi Tanabe Pharma and Osaka University Enter into Agreement 11
KAN Research Institute Enters into Development Agreement with Six Research Organizations 12
Mitsubishi Tanabe Pharma Forms Joint Venture with Research Foundation for Microbial Diseases of Osaka University 14
Oncolys Biopharma Enters into Research Agreement with Osaka University 15
BIKEN Enters into Distribution Agreement with Chiba Prefectural Institute of Health 16
Chugai Pharmaceutical Enters into Agreement with Osaka University 17
Takeda Pharma Enters Into Co-Marketing Agreement With Research Foundation For Microbial Diseases Of Osaka University 18
Takeda Pharma Enters Into Research Agreement With Osaka University 19
Japan Agency for Medical Research and Development Enters into Licensing Agreement with Osaka University 20
NobelPharma Enters into Licensing Agreement with Osaka University 21
BIKEN Enters into Licensing Agreement with Osaka University 22
FunPep Enters into Licensing Agreement with Osaka University 23
Osaka University, Key Competitors 24
Osaka University, Key Employees 25
Osaka University, Other Locations 26
Osaka University, Subsidiaries 26

List of Figures
Osaka University, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Osaka University, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Osaka University, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Osaka University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Osaka University, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Osaka University, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Osaka University, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Osaka University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Osaka University:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Petroleum Development Oman LLC:企業の戦略的SWOT分析
    Petroleum Development Oman LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • Cardiva Medical Inc:企業の戦略的SWOT分析
    Cardiva Medical Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • SL Green Realty Corp:企業のM&A・事業提携・投資動向
    SL Green Realty Corp - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's SL Green Realty Corp Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A …
  • Kinder Morgan Inc (KMI):石油・ガス:M&Aディール及び事業提携情報
    Summary Kinder Morgan Inc (KMI) is a midstream energy infrastructure company that owns and operates through a network of pipelines and terminals. Its pipelines transport natural gas, crude oil, gasoline, condensate, refined petroleum products and other products, and its terminals transload and store …
  • HDR Inc:企業の戦略的SWOT分析
    HDR Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This …
  • Aspial Corporation Ltd (A30):企業の財務・戦略的SWOT分析
    Aspial Corporation Ltd (A30) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Lansen Pharmaceutical Holdings Ltd (503):企業の財務・戦略的SWOT分析
    Summary Lansen Pharmaceutical Holdings Ltd (Lansen), a subsidiary of Cathay International Holdings Ltd is a pharmaceutical that develops, produces and sales specialty prescription western pharmaceuticals for the treatment of rheumatic diseases. The company’s products comprise specialist medicine, Ch …
  • Television Francaise 1 SA (TFI):企業の財務・戦略的SWOT分析
    Television Francaise 1 SA (TFI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Factor Therapeutics Ltd (FTT)-医療機器分野:企業M&A・提携分析
    Summary Factor Therapeutics Ltd (FTL), formerly Tissue Therapies Ltd is a developer of wound care therapeutics. The company develops treatments for acute and chronic wound healing applications such as chronic skin ulcers and burns. Its lead therapeutic candidate, VF-001 is a targeted growth factor w …
  • LegoChem Biosciences Inc (141080)-製薬・医療分野:企業M&A・提携分析
    Summary LegoChem Biosciences Inc (LCB) is a drug company that research and develops small molecule drugs. The company’s services include joint and contract research, chemical library package, compound synthesis and sales, and screening services. Its screening services include metabolic stability, pl …
  • KBC Group NV:企業の戦略・SWOT・財務情報
    KBC Group NV - Strategy, SWOT and Corporate Finance Report Summary KBC Group NV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Lietuvos energijos gamyba AB (LNR1L):企業の財務・戦略的SWOT分析
    Lietuvos energijos gamyba AB (LNR1L) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Salzgitter AG:企業の戦略・SWOT・財務分析
    Salzgitter AG - Strategy, SWOT and Corporate Finance Report Summary Salzgitter AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Dril-Quip Inc (DRQ):企業の財務・戦略的SWOT分析
    Dril-Quip Inc (DRQ) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Minesto AB (MINEST):電力:M&Aディール及び事業提携情報
    Summary Minesto AB (Minesto) is a marine energy technology developer. The company offers ervices such as renewable energy solutions, tidal power plants operations and management, power generation, and deep green technology solutions. It also provides control-system design, hydrodynamics, simulation, …
  • Toyota Tsusho Corporation (8015)-エネルギー分野:企業M&A・提携分析
    Summary Toyota Tsusho Corporation (Toyota Tsusho) is a diversified general trading and project management company. The company trades steel, aluminum, machinery, electronics, energy, chemicals, and other consumer products. It also provides passenger cars, buses, motorcycles, trucks, used vehicles, e …
  • Cal-Maine Foods Inc (CALM):企業の財務・戦略的SWOT分析
    Cal-Maine Foods Inc (CALM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Vivimed Labs Ltd (VIVIMEDLAB):企業の財務・戦略的SWOT分析
    Vivimed Labs Ltd (VIVIMEDLAB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Xeltis AG:企業の製品パイプライン分析2018
    Summary Xeltis AG (Xeltis) is a clinical-stage medical equipment company that harnesses advances in science to improve the treatment of heart valve related conditions. The company’s polymer-based technology platform, RestoreX, facilitates the natural restoration of heart valve through a process refe …
  • Bullfrog Power Inc.:電力:M&Aディール及び事業提携情報
    Summary Bullfrog Power Inc. (Bullfrog Power) is a provider of green energy. It offers renewable energy solutions that help businesses and houses in reducing their environmental impact. Bullfrog's product portfolio includes green electricity, green fuel and green natural gas. The company, through its …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆